Table 1.
Inhibitory effects of ginsenosides SF, Rk3, Rg6, and Rs4 on the TNF-α-induced NF-κB transcriptional activity and iNOS promoter activity in HepG2 and SK-Hep1 hepatocyte-derived cells
Ginsenoside or Compound | IC50 (μM)*
|
|||
---|---|---|---|---|
HepG2
|
SK-Hep1
|
|||
NF-κB | iNOS | NF-κB | iNOS | |
Ginsenoside SF | 33.86 ± 4.14 | 13.07 ± 0.64 | 18.17 ± 0.69 | 11.26 ± 0.87 |
Ginsenoside Rk3 | 14.24 ± 1.30 | 9.83 ± 0.06 | 15.32 ± 0.29 | 6.02 ± 0.37 |
Ginsenoside Rg6 | 29.34 ± 2.22 | 19.45 ± 0.55 | 25.12 ± 1.04 | 10.36 ± 0.69 |
Ginsenoside Rs4 | 12.44 ± 2.01 | 10.01 ± 1.21 | 11.98 ± 0.85 | 6.92 ± 0.65 |
Apigenin** | 1.64 ± 0.19 | 4.45 ± 0.24 | 3.60 ± 0.21 | 3.63 ± 0.17 |
Results are the means ± SEM of three independent experiments performed in triplicate.
Positive control. apigenin